Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

CRBU

Caribou Biosciences (CRBU)

Caribou Biosciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CRBU
DateTimeSourceHeadlineSymbolCompany
31/01/202508:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRBUCaribou Biosciences Inc
30/01/202521:45PR Newswire (US)Shareholders that lost money on Caribou Biosciences, Inc.(CRBU) Urged to Join Class Action - Contact The Gross Law Firm to Learn MoreNASDAQ:CRBUCaribou Biosciences Inc
27/01/202521:45PR Newswire (US)The Gross Law Firm Notifies Shareholders of Caribou Biosciences, Inc.(CRBU) of a Class Action Lawsuit and an Upcoming DeadlineNASDAQ:CRBUCaribou Biosciences Inc
23/01/202521:45PR Newswire (US)The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Caribou Biosciences, Inc.(CRBU) ShareholdersNASDAQ:CRBUCaribou Biosciences Inc
20/01/202521:45PR Newswire (US)Caribou Biosciences, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - CRBUNASDAQ:CRBUCaribou Biosciences Inc
16/01/202521:45PR Newswire (US)CRBU LAWSUIT ALERT: The Gross Law Firm Notifies Caribou Biosciences, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineNASDAQ:CRBUCaribou Biosciences Inc
14/01/202500:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRBUCaribou Biosciences Inc
13/01/202521:45PR Newswire (US)Shareholders of Caribou Biosciences, Inc. Should Contact The Gross Law Firm Before February 24, 2025 to Discuss Your Rights - CRBUNASDAQ:CRBUCaribou Biosciences Inc
13/01/202511:05GlobeNewswire Inc.Caribou Biosciences Initiates the CB-010 GALLOP Phase 1 Trial in Lupus and Provides Outlook for Multiple Clinical Datasets in 2025NASDAQ:CRBUCaribou Biosciences Inc
11/01/202509:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRBUCaribou Biosciences Inc
11/01/202508:55Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CRBUCaribou Biosciences Inc
09/01/202521:45PR Newswire (US)Class Action Filed Against Caribou Biosciences, Inc. (CRBU) Seeking Recovery for Investors - Contact The Gross Law FirmNASDAQ:CRBUCaribou Biosciences Inc
08/01/202508:00GlobeNewswire Inc.Caribou Biosciences to Present at 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:CRBUCaribou Biosciences Inc
06/01/202521:45PR Newswire (US)The Gross Law Firm Reminds Caribou Biosciences, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 24, 2025 - CRBUNASDAQ:CRBUCaribou Biosciences Inc
03/01/202504:50PR Newswire (US)Class Action Filed Against Caribou Biosciences, Inc. (CRBU) Seeking Recovery for Investors - Contact The Gross Law FirmNASDAQ:CRBUCaribou Biosciences Inc
03/01/202500:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRBUCaribou Biosciences Inc
03/01/202500:00GlobeNewswire Inc.Caribou Biosciences Appoints Sri Ryali as Chief Financial OfficerNASDAQ:CRBUCaribou Biosciences Inc
07/12/202408:06Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:CRBUCaribou Biosciences Inc
23/11/202408:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRBUCaribou Biosciences Inc
21/11/202408:00GlobeNewswire Inc.Caribou Biosciences to Participate in Upcoming Investor ConferencesNASDAQ:CRBUCaribou Biosciences Inc
15/11/202410:08Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:CRBUCaribou Biosciences Inc
07/11/202408:08Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CRBUCaribou Biosciences Inc
07/11/202408:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRBUCaribou Biosciences Inc
07/11/202408:05GlobeNewswire Inc.Caribou Biosciences Reports Third Quarter 2024 Financial Results and  Provides Business UpdateNASDAQ:CRBUCaribou Biosciences Inc
05/10/202406:02Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CRBUCaribou Biosciences Inc
28/09/202406:02Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:CRBUCaribou Biosciences Inc
25/09/202423:00GlobeNewswire Inc.Caribou Biosciences to Present Preclinical Data Supporting Development of CB-010 for Lupus at the American College of Rheumatology Convergence 2024NASDAQ:CRBUCaribou Biosciences Inc
04/09/202406:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRBUCaribou Biosciences Inc
03/09/202422:00GlobeNewswire Inc.Caribou Biosciences Announces the FDA has Granted Fast Track Designations to CB-010 in Refractory SLE and to CB-012 in Relapsed or Refractory AMLNASDAQ:CRBUCaribou Biosciences Inc
27/08/202406:00GlobeNewswire Inc.Caribou Biosciences to Participate in Upcoming Investor ConferencesNASDAQ:CRBUCaribou Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:CRBU